パーキンソン病：製薬企業動向...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers – Global Issues 16
4 Current and Future Players 19
4.1 Overview 19
4.2 Trends in Corporate Strategy 20
4.3 Company Profiles 21
4.3.1 Merck 21
4.3.2 Roche 23
4.3.3 AbbVie 25
4.3.4 UCB 27
4.3.5 GlaxoSmithKline 28
4.3.6 Novartis 30
4.3.7 Orion 33
4.3.8 Newron 35
4.3.9 Civitas 36
4.3.10 Impax 38
4.3.11 Lundbeck 40
5 Appendix 43
5.1 Bibliography 43
5.2 Abbreviations 47
5.3 Methodology 49
5.4 Forecasting Methodology 49
5.4.1 Diagnosed Parkinson’s disease Patients 49
5.4.2 Percent Drug-Treated Patients 50
5.4.3 General Pricing Assumptions 50
5.4.4 Compliance Assumptions 51
5.4.5 Generic Erosion 51
5.5 Physicians and Specialists Included in this Study 52
5.6 About the Authors 54
5.6.1 Author 54
5.6.2 Global Head of Healthcare 55
5.7 About GlobalData 56
5.8 Disclaimer 56